Blog

Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas

Sep 8 • 3 min read

Quick Take: The clinics will open in Austin and Bee Cave, Texas, and will be led by Illumma KetamineOne Capital Limited (NEO: MEDI) (OTC: KONEF), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has recently entered into a non-binding letter of…

Journey Colab secures $12M Series A funding for Phase 1 trial of Mescaline HCl, JOUR-001, for treatment of Alcohol Use Disorder

Sep 8 • 3 min read

Quick Take: Journey Colab has raised $12M in equity to fund the development of synthetically-derived psychedelic products These products are aimed at treating alcohol addiction, among other mental health disorders. Journey Colab Corp., a privately-held psychedelic pharmaceutical startup initially funded by Sam Altman and Apollo Projects, has raised $12M in new equity funding to develop…

Field Trip Health opens Europe’s first psychedelic therapy healthcare facility

Sep 7 • 3 min read

Quick Take: The facility will offer a team of psychiatrists and nurses to help guide patients in psychedelic therapy. Field Trip Health (TSX: FTRP), the world’s first facility for psychedelic-assisted psychotherapy, is thrilled to announce the opening of its new branch in Amsterdam. At Field Trip, a dedicated team of professionals, including psychiatrists, and nurses, guide people…

Filament Health Shares to Commence Trading on the OTC Market

Sep 7 • 3 min read

Quick Take: Filament has recieved approval from the Financial Regulatory Authority that it is qualified to begin trading on the OTC Pink Market. Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on…

MINDCURE Announces Financial Results for Fiscal 2021

Sep 3 • 3 min read

VANCOUVER, BC, August 31, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research in psychedelics, today announced its financial results for the three and twelve months ended May 31, 2021. All amounts are stated in Canadian dollars unless otherwise indicated. …

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538